Skip to main content
main-content

01.12.2012 | Case report | Ausgabe 1/2012 Open Access

World Journal of Surgical Oncology 1/2012

A long-term survival case of adult undifferentiated embryonal sarcoma of liver

Zeitschrift:
World Journal of Surgical Oncology > Ausgabe 1/2012
Autoren:
Keita Noguchi, Hideki Yokoo, Kazuaki Nakanishi, Tatsuhiko Kakisaka, Yosuke Tsuruga, Hirofumi Kamachi, Michiaki Matsushita, Toshiya Kamiyama
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-10-65) contains supplementary material, which is available to authorized users.

Competing interests

The author(s) declare that they have no competing interest.

Authors’ contribution

H Yokoo and T Kamiyama was involved in the review of loterature, acquisition of data and drafting and completing the manuscript. K Nakanishi, T Kakisaka, Y Tsuruga, H Kamachi and M Matsushita participated in the critical review of the paper. All authors read and approved the final manuscript.

Abstract

Undifferentiated embryonal sarcoma of the liver (USEL) is a rare malignant hepatic tumor with a poor prognosis that is usually observed in children (aged 6 to10 years) and rarely seen in adults. We present a case of USEL in a 27-year-old woman with no previous history of the disease. Laboratory tests performed on admission showed that the patient had mildly elevated levels of aspartate aminotransferase, alanine transaminase, alkaline phosphatase, lactate dehydrogenase, and γ-glutamyl transpeptidase. The levels of viral hepatitis and tumor serum markers were all within normal limits. Computed tomography showed a large mass involving the right lobe and the medial segment of the liver. Right trisectionectomy was performed. Microscopically, the tumor was composed of pleomorphic and polynuclear dyskaryotic cells in a myxoid stroma with focal eosinophilic globules and no clear differentiation to muscle. Histological diagnosis showed undifferentiated embryonal sarcoma. Adjuvant therapy with cisplatin, vincristine, doxorubicin, cyclophosphamide, and actinomycin D was initiated. We administered a high dose of etoposide to extract the patient’s peripheral blood stem cells and performed radiation therapy and peripheral blood stem cell transplantation. At 5-year follow-up, the patient was alive without any evidence of recurrence. Here, we describe the clinical and histopathological features of USEL as well as the therapeutic options for USEL in adults with this disease.
Zusatzmaterial
Authors’ original file for figure 1
12957_2011_990_MOESM1_ESM.gif
Authors’ original file for figure 2
12957_2011_990_MOESM2_ESM.jpeg
Authors’ original file for figure 3
12957_2011_990_MOESM3_ESM.gif
Authors’ original file for figure 4
12957_2011_990_MOESM4_ESM.tiff
Authors’ original file for figure 5
12957_2011_990_MOESM5_ESM.tiff
Authors’ original file for figure 6
12957_2011_990_MOESM6_ESM.tiff
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgical Oncology 1/2012 Zur Ausgabe

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise